DISA (EQACF) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
DISA Limited’s subsidiary, DLL, has successfully completed a trial deployment of its innovative Automated Visual Acuity Test device in a prominent Singapore public hospital, marking a significant step towards the device’s commercialization. The AVAT device, a pioneering solution in automated ophthalmology screening, is undergoing further trials in various clinics to expand its market reach. Additionally, DISA has strengthened its team with engineering and regulatory experts to boost the device’s commercial rollout.
For further insights into EQACF stock, check out TipRanks’ Stock Analysis page.
